China Health Group Inc. (FRA:VNL1)
Germany flag Germany · Delayed Price · Currency is EUR
0.0070
0.00 (0.00%)
Last updated: Dec 18, 2025, 3:29 PM CET

China Health Group Statistics

Total Valuation

FRA:VNL1 has a market cap or net worth of EUR 16.92 million. The enterprise value is 13.79 million.

Market Cap16.92M
Enterprise Value 13.79M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date Mar 27, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 995.35M
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) -0.00%
Owned by Insiders (%) 46.73%
Owned by Institutions (%) n/a
Float 288.87M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.78
PB Ratio 1.82
P/TBV Ratio 1.80
P/FCF Ratio 9.38
P/OCF Ratio 8.40
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -8.80
EV / Sales 3.85
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 7.64

Financial Position

The company has a current ratio of 3.23

Current Ratio 3.23
Quick Ratio 2.82
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -15.50% and return on invested capital (ROIC) is -9.52%.

Return on Equity (ROE) -15.50%
Return on Assets (ROA) -6.78%
Return on Invested Capital (ROIC) -9.52%
Return on Capital Employed (ROCE) -16.51%
Revenue Per Employee 80,450
Profits Per Employee -35,586
Employee Count42
Asset Turnover 0.25
Inventory Turnover n/a

Taxes

In the past 12 months, FRA:VNL1 has paid 33,638 in taxes.

Income Tax 33,638
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -44.00% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -44.00%
50-Day Moving Average 0.01
200-Day Moving Average 0.01
Relative Strength Index (RSI) 44.26
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:VNL1 had revenue of EUR 3.54 million and -1.57 million in losses. Loss per share was -0.00.

Revenue3.54M
Gross Profit 1.43M
Operating Income -1.54M
Pretax Income -1.53M
Net Income -1.57M
EBITDA -1.44M
EBIT -1.54M
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 3.02 million in cash and n/a in debt, giving a net cash position of 3.02 million.

Cash & Cash Equivalents 3.02M
Total Debt n/a
Net Cash 3.02M
Net Cash Per Share n/a
Equity (Book Value) 9.32M
Book Value Per Share 0.01
Working Capital 8.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.01 million and capital expenditures -209,315, giving a free cash flow of 1.80 million.

Operating Cash Flow 2.01M
Capital Expenditures -209,315
Free Cash Flow 1.80M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 40.39%, with operating and profit margins of -43.46% and -44.23%.

Gross Margin 40.39%
Operating Margin -43.46%
Pretax Margin -43.28%
Profit Margin -44.23%
EBITDA Margin -40.80%
EBIT Margin -43.46%
FCF Margin 50.97%

Dividends & Yields

FRA:VNL1 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -9.26%
FCF Yield 10.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:VNL1 has an Altman Z-Score of 2.97 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.97
Piotroski F-Score 5